[1]
Popovic, P. et al. 2026. Conversion Therapy for Advanced Hepatocellular Carcinoma Following Complete Response to Transarterial Radioembolization Combined with Atezolizumab and Bevacizumab. Radiology and Oncology. 60, 1 (Mar. 2026), 40–48.